Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
cbdMD, Inc. (YCBD)
|
Add to portfolio |
|
|
|
| Price: |
$1.11
| | Metrics |
| OS: |
2.86
|
M
| |
|
|
| Market cap: |
$3.17
|
M
| |
|
|
|
Net cash:
|
$4.24
|
M
| |
$1.49
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($7.0)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 |
| Revenues | 35.4 | 44.5 | 41.9 | 23.7 | 0.5 | 4.5 | 2.0 |
| Revenue growth | -20.4% | 6.2% | 77.1% | 5051.8% | -89.7% | 120.3% | |
| Cost of goods sold | 13.1 | 14.5 | 15.5 | 9.1 | 0.4 | 1.4 | 1.6 |
| Gross profit | 22.3 | 30.0 | 26.4 | 14.5 | 0.1 | 3.1 | 0.4 |
| Gross margin | 63.1% | 67.4% | 63.0% | 61.4% | 20.2% | 69.7% | 20.3% |
| Selling, general and administrative | | | 44.0 | 29.3 | 2.2 | 3.4 | 4.1 |
| Sales and marketing | 39.6 | 49.6 | | | | | |
| EBITA | -8.6 | -26.3 | -16.4 | -47.8 | -1.8 | -1.3 | -3.9 |
| EBITA margin | -24.2% | -59.1% | -39.2% | -201.9% | -391.4% | -29.3% | -191.4% |
| Amortization of intangibles | 0.9 | | 1.2 | | | | |
| EBIT | -9.4 | -26.3 | -17.6 | -47.8 | -1.8 | -1.3 | -3.9 |
| EBIT margin | -26.7% | -59.1% | -42.0% | -201.9% | -391.4% | -29.3% | -191.4% |
| Pre-tax income | -70.1 | -24.3 | 11.3 | -47.8 | -1.8 | 0.4 | -0.5 |
| Income taxes | 0.0 | -0.9 | 1.3 | -2.4 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 3.7% | 11.9% | 4.9% | 0.0% | 6.6% | |
| Earnings from continuing ops | -74.1 | -25.9 | 12.3 | -44.5 | -2.3 | -1.7 | -3.4 |
| Earnings from discontinued ops | | | 0.0 | -5.9 | 1.9 | | |
| Net income | -74.1 | -25.9 | 12.2 | -50.4 | -0.4 | -1.7 | -3.4 |
| Net margin | -209.3% | -58.3% | 29.2% | -213.2% | -89.8% | -38.9% | -165.2% |
| |
| Diluted EPS | ($1.24) | ($0.47) | $0.27 | ($2.49) | ($0.29) | ($0.38) | ($1.13) |
| Shares outstanding (diluted) | 59.8 | 54.9 | 45.2 | 17.9 | 7.7 | 4.5 | 3.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|